Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis

BACKGROUND: Standard treatment for stage I or non-bulky stage II diffuse large B-cell lymphoma (DLBCL) has been either a brief course of chemotherapy plus involved-field radiotherapy (IFRT) or prolonged cycles of chemotherapy. The introduction of rituximab has necessitated re-evaluation of the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Junshik, Kim, Ae Jin, Park, Jin Sun, Lee, Seok Ho, Lee, Kyu Chan, Park, Jinny, Sym, Sun Jin, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon
Formato: Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023051/
https://www.ncbi.nlm.nih.gov/pubmed/21253427
http://dx.doi.org/10.5045/kjh.2010.45.4.253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023051/
https://www.ncbi.nlm.nih.gov/pubmed/21253427
http://dx.doi.org/10.5045/kjh.2010.45.4.253

Ejemplares similares